United States · FDA National Drug Code directory
IMITREX
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0173-0739_9770a6f8-f25f-48e7-a513-4a26bb43b5c1
- Product NDC
- 0173-0739
- Form
- INJECTION
- Composition / generic term
- sumatriptan
- Labeler
- GlaxoSmithKline LLC
- Marketing category
- NDA
- Marketing start / end (source format)
- 20060406
- Source listing expiry
- 20271231
Source-listed ingredients
- SUMATRIPTAN SUCCINATE — 4 mg/.5mL
These values do not establish equivalence or a dose recommendation.
Packages
- 2 SYRINGE in 1 PACKAGE (0173-0739-00) / .5 mL in 1 SYRINGE · 0173-0739-00
- 2 SYRINGE in 1 CARTON (0173-0739-02) / .5 mL in 1 SYRINGE · 0173-0739-02
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →